Pharmacophore and structure-based drug design, molecular dynamics and admet/tox studies to design novel potential pad4 inhibitors
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacophore and structure-based drug design, molecular dynamics and admet/tox studies to design novel potential pad4 inhibitors
Authors
Keywords
-
Journal
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
Volume -, Issue -, Pages 1-16
Publisher
Informa UK Limited
Online
2018-03-01
DOI
10.1080/07391102.2018.1444511
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Combined pharmacophore, virtual screening and molecular dynamics studies to identify Bruton’s tyrosine kinase inhibitors
- (2018) Seethalakshmi Sakthivel et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- 3D descriptors calculation and conformational search to investigate potential bioactive conformations, with application in 3D-QSAR and virtual screening in drug design
- (2016) Carlos Henrique Tomich de Paula da Silva et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Identification of novel acetylcholinesterase inhibitors through e-pharmacophore-based virtual screening and molecular dynamics simulations
- (2016) Ruchi Malik et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Design, Synthesis, and Biological Evaluation of Tetrazole Analogs of Cl-Amidine as Protein Arginine Deiminase Inhibitors
- (2015) Venkataraman Subramanian et al. JOURNAL OF MEDICINAL CHEMISTRY
- Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation
- (2015) Huw D Lewis et al. Nature Chemical Biology
- Diabetes primes neutrophils to undergo NETosis, which impairs wound healing
- (2015) Siu Ling Wong et al. NATURE MEDICINE
- Citrullination unravels stem cells
- (2014) Daniel J Slade et al. Nature Chemical Biology
- Phospholipase A2 Inhibitors Isolated From Medicinal Plants: Alternative Treatment Against Snakebites
- (2013) Lorane Hage-Melim et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Anticancer Peptidylarginine Deiminase (PAD) Inhibitors Regulate the Autophagy Flux and the Mammalian Target of Rapamycin Complex 1 Activity
- (2012) Yuji Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Computer-aided Drug Design of Novel PLA2Inhibitor Candidates for Treatment of Snakebite
- (2012) Lorane Izabel da S. Hage-Melim et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- d-Amino Acid-Based Protein Arginine Deiminase Inhibitors: Synthesis, Pharmacokinetics, and in Cellulo Efficacy
- (2012) Kevin L. Bicker et al. ACS Medicinal Chemistry Letters
- Synthesis and Screening of a Haloacetamidine Containing Library To Identify PAD4 Selective Inhibitors
- (2011) Justin E. Jones et al. ACS Chemical Biology
- Homology modelling, virtual screening and molecular dynamics of the MARK3 KA1 domain for cancer drug design
- (2011) Evandro P. Semighini et al. MOLECULAR SIMULATION
- PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps
- (2010) Pingxin Li et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Computer-aided drug design and ADMET predictions for identification and evaluation of novel potential farnesyltransferase inhibitors in cancer therapy
- (2009) Carlos Henrique Tomich de Paula da Silva et al. JOURNAL OF MOLECULAR GRAPHICS & MODELLING
- Molecular Dynamics, Density Functional, ADMET Predictions, Virtual Screening, and Molecular Interaction Field Studies for Identification and Evaluation of Novel Potential CDK2 Inhibitors In Cancer Therapy†
- (2008) Vinicius Barreto da Silva et al. JOURNAL OF PHYSICAL CHEMISTRY A
- Profiling Protein Arginine Deiminase 4 (PAD4): A novel screen to identify PAD4 inhibitors
- (2007) Bryan Knuckley et al. BIOORGANIC & MEDICINAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now